Collegium Pharmaceutical, Inc.

COLLNASDAQHealthcare● Active

$33.27

$-0.11(-0.33%)

Market Cap$1.1B

P/E Ratio—

52W High$50.787

52W Low$29.08

Avg Volume530K

Open$33.43

Beta0.75

Free Cash Flow Financials Revenue

Collegium Pharmaceutical, Inc. (COLL) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

COLL · free cash flow · updated Jun 9, 2026

Core FCF metrics

COLL · FCF · TTM · margin & CAGR

Free cash flow was $327.6M for FY2025 (fiscal year ending 2025-12-31), up 61.1% year-over-year The FCF margin was 42.0%.

FY2025 Free Cash Flow$327.6M▲ +61.1% YoY

Trailing 12M (TTM)$329.8Mtrailing 4 quarters sum

FCF Margin42.0%$327.6M ÷ revenue

3-Year CAGR+38.8%FY2022 → FY2025

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

COLL · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$329.3M(2M)$327.6M▲ +61.1%42.0%

FY2024$205.0M(2M)$203.3M▼ 25.9%32.2%

FY2023$274.7M(0M)$274.3M▲ +123.7%48.4%

FY2022$124.2M(2M)$122.6M▲ +20.7%26.4%

FY2021$103.6M(2M)$101.6M▲ +136.3%36.7%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

COLL · P/FCF · FCF yield · FCF per share

Collegium Pharmaceutical, Inc. (COLL) trades at a FCF yield of 30.57% and a price-to-free-cash-flow ratio of 3.2x. FCF per share stands at $10.40, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

30.57%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$10.40

TTM FCF ÷ Shares Outstanding

Price / FCF

x3.2

Share Price ÷ FCF per Share

EV / FCF (TTM)

x4.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

COLL · cash flow statement · operating / investing / financing

For FY2025, Collegium Pharmaceutical, Inc. generated $329.3M in operating cash flow and spent 2M in capital expenditures, yielding $327.6M in free cash flow.

Operating Activities

+$329.3M

Cash from core business operations

2025-12-31

Investing Activities

−$63.5M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$110.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($329.3M) − |CapEx| (2M) = FCF ($327.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

COLL vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Collegium Pharmaceutical, Inc.YOU

COLL

$327.6M+61.1%42.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Collegium Pharmaceutical, Inc. (COLL) reported free cash flow of $327.6M for FY2025 (fiscal year ending 2025-12-31), up 61.1% year-over-year. The FCF margin was 42.0%.

Based on available data, Collegium Pharmaceutical, Inc. has maintained positive free cash flow for at least 7 fiscal year(s). FCF peaked at $327.6M in FY2025.

Collegium Pharmaceutical, Inc.'s FCF yield is 30.57% and price-to-FCF ratio is 3.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

COLL free cash flow · 8 questions

Collegium Pharmaceutical, Inc. free cash flow was $327.6M for FY2025, up 61.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $329.8M.

COLL free cash flowCOLL FCFCOLL FCF 2025COLL free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Collegium Pharmaceutical, Inc. · Collegium Pharmaceutical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026